Sees FY25 revenue $1.47B-$1.49B, consensus $1.48B. Lampropoulos continued: “We are introducing 2025 financial guidance which reflects confidence in our team’s ability to deliver continued strong execution, stable constant currency growth, improving profitability and solid free cash flow generation. We also remain focused on our Continued Growth Initiatives Program and on achieving the related financial targets for the three-year period ending December 31, 2026.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical reports Q4 EPS 93c, consensus 83c
- MMSI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Merit Medical price target raised to $118 from $103 at BofA
- Merit Medical price target raised to $115 from $114 at Barrington
- Merit Medical price target raised to $116 from $114 at Piper Sandler